ARCHIVES

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

This article is from The Cancer Letter archive.

Vol. 26 No. 35 | September 29, 2000

Download PDF Visit The Full Archive

Related Articles

More RFPs Coming On X-Ray imaging For Early Diagnosis, Including Sound

August 23, 1974

Congress Asked To Equalize Cuts, Add $20 million For Centers

April 25, 1980

Cooperative Group Chairman Objects “Personal” Comments, Other Deficiencies In Peer Review

January 16, 1981

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

September 27, 2013

Broder To Leave In March; Sondik To Be Acting Director

January 27, 1995

Leukemia Society Program In Transitional Research.

January 14, 2000